Breaking News Instant updates and real-time market news.

ABT

Abbott

$69.05

0.25 (0.36%)

16:15
09/23/18
09/23
16:15
09/23/18
16:15

Abbott announces positive clinical study results from MitraClip trial

Abbott announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip device to guideline-directed medical therapy in select patients with secondary mitral regurgitation, or a leaky heart valve, as a result of advanced heart failure. The landmark COAPT study met both the primary safety and efficacy endpoints and all secondary endpoints, and showed treatment with MitraClip plus medical therapy was superior to medical therapy alone in reducing rates of heart failure hospitalizations and improving survival at two years. This therapeutic mitral valve intervention is the first and only to demonstrate positive outcomes in a clinical trial for ailing heart failure patients with clinically significant secondary mitral regurgitation. The COAPT study data will be submitted to the U.S. Food and Drug Administration to support consideration of an expanded indication for Abbott's MitraClip to treat secondary mitral regurgitation. Treatment with MitraClip plus medical therapy resulted in a statistically significant reduction in heart failure hospitalization through two years compared to medical therapy alone. MitraClip treatment reduced all-cause mortality through two years, from 46.1% of patients in the control group to 29.1% in the device group at two years of follow-up. At one year, freedom from device-related complications was 96.6%, exceeding the performance goal for the primary safety endpoint. Patients in the device group experienced significant reduction in MR severity and NYHA class. Treatment with MitraClip provided a substantial improvement in patients' perception of their health status, measured by the KCCQ quality-of-life score, and functional capacity at one year. MitraClip treatment resulted in a reduction in the composite of death or first heart failure hospitalization by 43.0%. The results were consistent across numerous subgroups, including patients with ischemic and non-ischemic cardiomyopathy - a disease of the heart muscle that weakens the ability of the heart to pump blood to the rest of the body - and those at high and low surgical risk.

  • 17

    Oct

ABT Abbott
$69.05

0.25 (0.36%)

08/07/18
NEED
08/07/18
NO CHANGE
Target $74
NEED
Buy
Surmodics price target raised to $74 from $55 at Needham
Needham analyst Mike Matson raised his price target on Surmodics (SRDX) to $74 and kept his Buy rating after its Q3 earnings beat and raised FY18 outlook. The analyst anticipates accelerating revenue growth with more upside to consensus estimates coming from the company's new products such as the .014'' and .018" balloon dilation catheters and Telemark microcatheter, along with its deferred revenue associated with the Abbott (ABT) agreement milestones.
09/05/18
PIPR
09/05/18
NO CHANGE
Target $150
PIPR
Overweight
Piper says investors need exposure to CGM market, prefers DexCom
The strong growth of the continuous glucose monitoring market seen in Q2 will continue for the next several years as CGM pushes towards standard of care in Type 1 diabetes and shows healthy adoption from insulin using Type 2s, Piper Jaffray analyst JP McKim tells investors in a research note. For mass adoption, pricing will need to come down, but even at $3-$4 per day in developed markets CGM is still an $80B worldwide addressable market, the analyst says. He thinks investors "need to have exposure" to the CGM market, and DexCom (DXCM) remains his favorite way to play the space. McKim keeps an Overweight rating on the shares with a $150 price target. He points out that Abbott (ABT), Dexcom and even Medtronic (MDT) posted CGM numbers in Q2 that were much better than expected.
09/10/18
ADAM
09/10/18
NO CHANGE
Target $80
ADAM
Buy
Quidel could draw interest from a larger company, says Canaccord
Canaccord analyst Mark Massaro remains positive on Quidel (QDEL) after hosting meetings with management. The analyst cited rising demand for its new products and he expects the company to continue to take market share from larger companies Alere (ABT) and Becton Dickinson (BDX). He also believes the company could draw interest from a larger company, like the bid Alere got from Abbott. Massaro reiterated his Buy rating and raised his price target to $80 from $78 on Quidel shares.
09/18/18
PIPR
09/18/18
NO CHANGE
Target $150
PIPR
Overweight
DexCom supply constraints getting better, says Piper Jaffray
Piper Jaffray analyst JP McKim says his latest channel checks on DexCom (DXCM) show that supply is still constrained but getting better. Further, the checks indicate that Abbott's (ABT) Libre 14 day sensor is the same price as the 10 day on a per day basis and should be launching in the next month, McKim tells investors in a research note. While it is "too soon to blow the all clear horn" on DexCom's supply issues, things are "improving steadily" and the demand for the company's G6 remains robust, the analyst contends. He believes the continuous glucose monitoring market is "really taking off" and expects continued strong results from DexCom in both Q3 and Q4. McKim keeps an Overweight rating on the shares with a $150 price target.

TODAY'S FREE FLY STORIES

22:45
10/15/18
10/15
22:45
10/15/18
22:45
General news
China's CPI grew 2.5% y/y in September »

China's CPI grew…

PYPL

PayPal

$77.22

-1.8 (-2.28%)

20:49
10/15/18
10/15
20:49
10/15/18
20:49
Recommendations
PayPal analyst commentary at Stifel »

PayPal earnings to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 26

    Nov

ALRM

Alarm.com

$44.50

0.16 (0.36%)

20:45
10/15/18
10/15
20:45
10/15/18
20:45
Upgrade
Alarm.com rating change at First Analysis »

Alarm.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SGBAF

SES S.A.

$0.00

(0.00%)

20:36
10/15/18
10/15
20:36
10/15/18
20:36
Upgrade
SES S.A. rating change at JPMorgan »

SES S.A. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, UNH

UnitedHealth

$259.80

0.36 (0.14%)

20:25
10/15/18
10/15
20:25
10/15/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

UNH

UnitedHealth

$259.80

0.36 (0.14%)

GS

Goldman Sachs

$215.28

1.37 (0.64%)

MS

Morgan Stanley

$43.45

(0.00%)

BLK

BlackRock

$427.40

-0.18 (-0.04%)

PLD

Prologis

$63.00

0.45 (0.72%)

PGR

Progressive

$66.23

-0.64 (-0.96%)

GWW

Grainger

$318.38

6.75 (2.17%)

OMC

Omnicom

$69.48

0.8 (1.16%)

CMA

Comerica

$83.69

-1.04 (-1.23%)

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

DPZ

Domino's Pizza

$273.13

-4.215 (-1.52%)

FHN

First Horizon

$15.99

-0.11 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 27

    Nov

  • 24

    Jan

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

20:13
10/15/18
10/15
20:13
10/15/18
20:13
Recommendations
Twilio, SendGrid analyst commentary at MUFG »

MUFG analyst 'fully…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

20:07
10/15/18
10/15
20:07
10/15/18
20:07
Recommendations
Palo Alto Networks analyst commentary at JPMorgan »

Palo Alto Networks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

SVA

Sinovac Biotech

$7.16

-0.03 (-0.42%)

20:03
10/15/18
10/15
20:03
10/15/18
20:03
Hot Stocks
Sinovac Biotech commences legal proceedings in Hong Kong »

Senior management of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWN

Northwest Natural Gas

$67.70

0.36 (0.53%)

20:01
10/15/18
10/15
20:01
10/15/18
20:01
Hot Stocks
Northwest Natural Water unit to buy Sunriver Water LLC, terms not stated »

NW Natural Water Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VFC

VF Corp.

$87.65

0.11 (0.13%)

19:53
10/15/18
10/15
19:53
10/15/18
19:53
Initiation
VF Corp. initiated at Wedbush »

VF Corp. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

LVS

Las Vegas Sands

$55.84

-0.32 (-0.57%)

19:39
10/15/18
10/15
19:39
10/15/18
19:39
Upgrade
Las Vegas Sands rating change at HSBC »

Las Vegas Sands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$72.24

-4.69 (-6.10%)

19:37
10/15/18
10/15
19:37
10/15/18
19:37
Recommendations
Occidental Petroleum analyst commentary at MUFG »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AVMXY

Avita Medical

$0.00

(0.00%)

19:24
10/15/18
10/15
19:24
10/15/18
19:24
Hot Stocks
Avita Medical announces Recell trial results presentation »

AVITA Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

19:16
10/15/18
10/15
19:16
10/15/18
19:16
Hot Stocks
Facebook confirms expanding policies on voter suppression »

Facebook said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

18:58
10/15/18
10/15
18:58
10/15/18
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: J.B.…

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

SEND

SendGrid

$30.94

0.04 (0.13%)

TWLO

Twilio

$76.26

1.27 (1.69%)

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

ADBE

Adobe

$238.05

-10.84 (-4.36%)

CRY

CryoLife

$30.64

0.42 (1.39%)

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

JELD

Jeld-Wen

$21.31

-0.04 (-0.19%)

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

AGN

Allergan

$183.03

-0.275 (-0.15%)

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

SNAP

Snap

$7.41

0.225 (3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 25

    Oct

  • 30

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 27

    Nov

  • 10

    Dec

SHLD

Sears

$0.31

-0.0901 (-22.52%)

18:43
10/15/18
10/15
18:43
10/15/18
18:43
Hot Stocks
Sears receives court approval of 'first day' motions to support business ops »

Sears Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$97.03

1.63 (1.71%)

18:38
10/15/18
10/15
18:38
10/15/18
18:38
Upgrade
Wabtec rating change at Wellington Shields »

Wabtec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

18:30
10/15/18
10/15
18:30
10/15/18
18:30
Hot Stocks
Tallgrass Energy, Silver Creek Midstream to expand Powder River Basin JV »

Tallgrass Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.47

0.86 (0.76%)

, GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

18:21
10/15/18
10/15
18:21
10/15/18
18:21
Hot Stocks
Disney-backed Jaunt to focus efforts on AR, says some staff will be 'moving on' »

Jaunt, a top-funded VR…

DIS

Disney

$113.47

0.86 (0.76%)

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 08

    Nov

  • 03

    Mar

HMC

Honda

$27.05

-0.16 (-0.59%)

18:19
10/15/18
10/15
18:19
10/15/18
18:19
Hot Stocks
Honda to recall 54 model year 2017-2018 Honda Civic and Honda CR-V vehicles »

American Honda will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MSFT

Microsoft

$107.60

-1.94 (-1.77%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Microsoft co-founder Paul Allen dead at 65 »

Vulcan Inc. released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

OII

Oceaneering

$25.69

0.4 (1.58%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Oceaneering provides update following Hurricane Michael »

Oceaneering International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

JOE

Saint Joe Co.

$15.28

0.01 (0.07%)

18:07
10/15/18
10/15
18:07
10/15/18
18:07
Hot Stocks
Saint Joe released additional information regarding Hurricane Michael »

The St. Joe Company …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.41

0.055 (0.36%)

18:05
10/15/18
10/15
18:05
10/15/18
18:05
Periodicals
Petrobras anticipates reviving TAG sale over next month, Reuters says »

Petrobras expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$238.05

-10.84 (-4.36%)

18:02
10/15/18
10/15
18:02
10/15/18
18:02
Hot Stocks
Adobe says it sees increased demand for PDF capabilities »

Says it has over 300,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.